**** Drug Labelers with Outstanding Balances as reported to CMS ****
**** Tip of the Day ****
In response to Zika virus concerns, effective July 1st, 2016, select insect repellant will be covered
for traditional Delaware Medicaid (Fee-for-Service) clients. A valid prescription from an authorized
practitioner is required, and the products do have a per client limitation of one bottle per 30 days.
UnitedHealthCare Community Plan of Delaware 1-800-842-4195
|Click here for list of State Non-Participating Drug Manufacturers|
|Click here for the DPAP Application form|
*** Drug Rebate Documents *** |
Click here for information on web invoicing: Delaware Web Invoicing Information
*** Please complete both documents for each labeler code when applying for Electronic Invoicing ***
Click here for the application for electronic invoicing
Click here for the current Memorandum of understanding for electronic invoicing
for claim level detail files from 2Q2015 on.
Click here for the previous Memorandum of understanding for electronic invoicing
for claim level detail files between 4Q2011 and 1Q2015.
For questions on web invoicing, email: MoveItDocumentTransfer@hpe.com
*** Current W9 ***
Click here for current W-9 for Drug Rebate
*** Contact Us ***
For any questions related to Drug Rebate, email: DEDrugRebate@hpe.com
Attention Medical and Pharmacy Providers
In preparation for Delaware Medicaid Enterprise System (DMES) POS claim submission processing system, the current claims proce ssing system for fee-for-service clients will not be available from midnight on Thursday 12/22/2016 through Wednesday 12/28/20 16. NOTE: Managed care members will NOT be affected by this outage, so if a client has Highmark Health Options or UnitedHealthcare Community Plan, this communication does not apply to them. Please help your clients plan ahead for prescriptions they will need filled between these dates by reading DMMA's guidance under Pharmacy POS Downtime Alert.
The PDL document has been updated from the September meeting.
The updated PDL is available under the PDL List link on this page. The implementation date for each drug class is listed below the category and will be January 1st, 2017 for the majority.
Please contact Pharmacy Services at 1.800.999.3371 select option 0, select option 1 for further clarification
Pharmaceutical and Therapeutics (P&T) Committee
The Pharmaceutical and Therapeutics (P&T) Committee has been established by DMMA to provide clinical leadership in the selection of preferred medications. This selection will be based on a review of the relative clinical effectiveness and cost of products within selected therapeutic classes. The program's objective is to achieve quality pharmaceutical care for recipients enrolled in the Department's Medicaid programs while providing significant state savings.
- P & T Committee Meeting -
The Delaware P&T meeting is scheduled for Thursday, September 8th, 2016.
1:30 p.m. - 6:00 p.m.
Delaware Technical Community College
400 Stanton - Christiana Road
Newark, DE 19713
Directions to Stanton Campus
*Times listed are approximations. The public portion of the meeting will start NO EARLIER then the time listed and may be subject to delays.
Please contact Pharmacy Services at 1-800-999-3371 select option 0, select option 1 for further clarification.
Categories for Review